Literature DB >> 33510639

Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis.

Anastasia V Poznyak1, Nikita G Nikiforov2,3,4,5, Alexander M Markin4, Dmitry A Kashirskikh4, Veronika A Myasoedova5,6, Elena V Gerasimova7, Alexander N Orekhov1,4,5.   

Abstract

Cardiovascular pathologies maintain the leading position in mortality worldwide. Atherosclerosis is a chronic disease that can result in a variety of serious complications, such as myocardial infarction, stroke, and cardiovascular disease. Inflammation and lipid metabolism alterations play a crucial role in atherogenesis, but the details of relationships and causality of these fundamental processes remain not clear. The oxidation of LDL was considered the main atherogenic modification of LDL within the vascular wall for decades. However, recent investigations provided a growing body of evidence in support of the multiple LDL modification theory. It suggests that LDL particles undergo numerous modifications that change their size, density, and chemical properties within the blood flow and vascular wall. Oxidation is the last stage in this cascade resulting in the atherogenic properties. Moreover, recent investigations have discovered that oxLDL may have both anti-inflammatory and pro-inflammatory properties. Oxidized LDL can trigger inflammation through the activation of macrophages and other cells. After all, oxidized LDL is still a promising object for further investigations that have the potential to clarify the unknown parts of the atherogenic process. In this review, we discuss the role of oxLDL in atherosclerosis development on different levels.
Copyright © 2021 Poznyak, Nikiforov, Markin, Kashirskikh, Myasoedova, Gerasimova and Orekhov.

Entities:  

Keywords:  atherosclerosis; cardiovascular disease; low-density lipoprotein; oxLDL; oxidative stress

Year:  2021        PMID: 33510639      PMCID: PMC7836017          DOI: 10.3389/fphar.2020.613780

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  99 in total

1.  Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?

Authors:  Daniel Steinberg; Joseph L Witztum
Journal:  Circulation       Date:  2002-04-30       Impact factor: 29.690

Review 2.  Role of oxidative modifications in atherosclerosis.

Authors:  Roland Stocker; John F Keaney
Journal:  Physiol Rev       Date:  2004-10       Impact factor: 37.312

Review 3.  Role of xanthine oxidoreductase as an antimicrobial agent.

Authors:  Hannah M Martin; John T Hancock; Vyv Salisbury; Roger Harrison
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

4.  Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.

Authors:  Tomoya Hara; Pham Tran Phuong; Daiju Fukuda; Koji Yamaguchi; Chie Murata; Sachiko Nishimoto; Shusuke Yagi; Kenya Kusunose; Hirotsugu Yamada; Takeshi Soeki; Tetsuzo Wakatsuki; Issei Imoto; Michio Shimabukuro; Masataka Sata
Journal:  Circulation       Date:  2018-10-16       Impact factor: 29.690

5.  Silica nanoparticles promote oxLDL-induced macrophage lipid accumulation and apoptosis via endoplasmic reticulum stress signaling.

Authors:  Caixia Guo; Ru Ma; Xiaoying Liu; Tian Chen; Yang Li; Yang Yu; Junchao Duan; Xianqing Zhou; Yanbo Li; Zhiwei Sun
Journal:  Sci Total Environ       Date:  2018-03-16       Impact factor: 7.963

6.  Xanthine oxidase inhibition attenuates endothelial dysfunction caused by chronic intermittent hypoxia in rats.

Authors:  John M Dopp; Nathan R Philippi; Noah J Marcus; E Burt Olson; Cynthia E Bird; John J M Moran; Scott W Mueller; Barbara J Morgan
Journal:  Respiration       Date:  2011-08-12       Impact factor: 3.580

7.  Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice.

Authors:  June Liu; Douglas P Thewke; Yan Ru Su; MacRae F Linton; Sergio Fazio; Michael S Sinensky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-10-21       Impact factor: 8.311

Review 8.  Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction.

Authors:  Felix Fleissner; Thomas Thum
Journal:  Antioxid Redox Signal       Date:  2010-12-13       Impact factor: 8.401

Review 9.  NADPH oxidases in vascular pathology.

Authors:  Anna Konior; Agata Schramm; Marta Czesnikiewicz-Guzik; Tomasz J Guzik
Journal:  Antioxid Redox Signal       Date:  2013-11-01       Impact factor: 8.401

10.  Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.

Authors:  Jan Borén; M John Chapman; Ronald M Krauss; Chris J Packard; Jacob F Bentzon; Christoph J Binder; Mat J Daemen; Linda L Demer; Robert A Hegele; Stephen J Nicholls; Børge G Nordestgaard; Gerald F Watts; Eric Bruckert; Sergio Fazio; Brian A Ference; Ian Graham; Jay D Horton; Ulf Landmesser; Ulrich Laufs; Luis Masana; Gerard Pasterkamp; Frederick J Raal; Kausik K Ray; Heribert Schunkert; Marja-Riitta Taskinen; Bart van de Sluis; Olov Wiklund; Lale Tokgozoglu; Alberico L Catapano; Henry N Ginsberg
Journal:  Eur Heart J       Date:  2020-06-21       Impact factor: 29.983

View more
  42 in total

1.  Accumulation of LDL/ox-LDL in the necrotic region participates in osteonecrosis of the femoral head: a pathological and in vitro study.

Authors:  Xin-Yuan Wang; Tian-Le Ma; Kang-Ning Chen; Zhi-Ying Pang; Hao Wang; Jun-Ming Huang; Guo-Bin Qi; Chen-Zhong Wang; Zeng-Xin Jiang; Lin-Jing Gong; Zhe Wang; Chang Jiang; Zuo-Qin Yan
Journal:  Lipids Health Dis       Date:  2021-11-25       Impact factor: 3.876

2.  ZAKβ Alleviates Oxidized Low-density Lipoprotein (ox-LDL)-Induced Apoptosis and B-type Natriuretic Peptide (BNP) Upregulation in Cardiomyoblast.

Authors:  Ying-Ming Liou; Chih-Yang Huang; Yueh-Min Lin; Jiro Hasegawa Situmorang; Jia-Zun Guan; Dennis Jine-Yuan Hsieh; Jaw-Ji Yang; Michael Yu-Chih Chen; Ching-Hui Loh; Chia-Hua Kuo; Shang-Yeh Lu
Journal:  Cell Biochem Biophys       Date:  2022-07-01       Impact factor: 2.989

Review 3.  The Role of Polyphenol in Modulating Associated Genes in Diabetes-Induced Vascular Disorders.

Authors:  Nor Anizah Mohd Nor; Siti Balkis Budin; Satirah Zainalabidin; Juriyati Jalil; Syaifuzah Sapian; Fatin Farhana Jubaidi; Nur Najmi Mohamad Anuar
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

4.  Minimally Oxidized-LDL-Driven Alterations in the Level of Pathological Mediators and Biological Processes in Carotid Atherosclerosis.

Authors:  Finosh G Thankam; Taj Rai; Jeffrey Liu; Jonathan Tam; Devendra K Agrawal
Journal:  Cardiol Cardiovasc Med       Date:  2022-04-12

5.  Effect of combined lipid-lowering and antioxidant nutraceutical on plasma lipids, endothelial function, and estimated cardiovascular disease risk in moderately hypercholesterolemic patients: a double-blind, placebo-controlled randomized clinical trial.

Authors:  Arrigo F G Cicero; Marilisa Bove; Raffaele I Cincione; Federica Fogacci; Maddalena Veronesi
Journal:  Arch Med Sci Atheroscler Dis       Date:  2021-06-30

Review 6.  Tannins as Hemostasis Modulators.

Authors:  Natalia Marcińczyk; Anna Gromotowicz-Popławska; Michał Tomczyk; Ewa Chabielska
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

Review 7.  Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD.

Authors:  Anastasia V Poznyak; Dwaipayan Bharadwaj; Gauri Prasad; Andrey V Grechko; Margarita A Sazonova; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

8.  Helicobacter pylori Infection Acts Synergistically with a High-Fat Diet in the Development of a Proinflammatory and Potentially Proatherogenic Endothelial Cell Environment in an Experimental Model.

Authors:  Agnieszka Krupa; Weronika Gonciarz; Paulina Rusek-Wala; Tomasz Rechciński; Adrian Gajewski; Zuzanna Samsel; Anna Dziuba; Agnieszka Śmiech; Magdalena Chmiela
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

Review 9.  Exosome-Based Treatment for Atherosclerosis.

Authors:  Jeongyeon Heo; Hara Kang
Journal:  Int J Mol Sci       Date:  2022-01-17       Impact factor: 5.923

10.  TDP43 Exacerbates Atherosclerosis Progression by Promoting Inflammation and Lipid Uptake of Macrophages.

Authors:  Ning Huangfu; Yong Wang; Zhenyu Xu; Wenyuan Zheng; Chunlan Tao; Zhenwei Li; Yewen Hu; Xiaomin Chen
Journal:  Front Cell Dev Biol       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.